ERBB2 and neoplasm: Of note, ERBB2-CAR CIK cells, but not WT CIK cells were detectable by PCR at tumor sites (Figure 3F), albeit at lower levels compared to preemptive ERBB2-CAR CIK cell therapy (Figure 2G).